Description
This multi-action topical formulation combines powerful antibacterial, antifungal, anti-inflammatory, and antimicrobial agents to provide broad-spectrum treatment for various skin infections. It is designed to help manage mixed bacterial and fungal infections, inflammatory skin conditions, and associated symptoms such as redness, itching, irritation, and discomfort.
Ofloxacin (0.75% w/w) is a fluoroquinolone antibacterial agent that works by inhibiting bacterial DNA synthesis, effectively targeting a wide range of gram-positive and gram-negative bacteria.
Ornidazole (2.0% w/w) offers antiprotozoal and anaerobic antibacterial activity, helping eliminate organisms commonly involved in stubborn or recurrent skin infections.
Itraconazole (1.00% w/w) is a broad-spectrum antifungal effective against dermatophytes, yeasts, and molds, making the formulation suitable for fungal infections like ringworm, athlete’s foot, and candidiasis.
Clobetasol Propionate (0.05% w/w) is a potent corticosteroid that reduces inflammation, itching, redness, and swelling, providing quick symptomatic relief in inflammatory dermatoses.
Methylparaben (0.20% w/w) and Propylparaben (0.02% w/w) act as preservatives to maintain product stability and prevent microbial contamination.
Dermajest is used to manage skin conditions where bacterial, fungal, and inflammatory components coexist. It helps promote healing, soothe irritation, and restore skin comfort. The formulation is typically applied as directed by a healthcare professional, ensuring safe and effective use.
Its broad-spectrum activity makes it suitable for use in various dermatological infections; however, it should be used only under medical supervision to avoid inappropriate or prolonged application of potent corticosteroids or antimicrobials.
